Vitamine D Treatment in Chronic Heart Failure
Effects of 25-OH-D3 Vitamin Substitution in Congestive Heart Failure. Controlled, Randomized, Double Blind Trial
Sponsor: Semmelweis University
Terminated
financial reasons / insufficient enrollment activity
Other terminated trials from Semmelweis University
Other Chronic Heart Failure trials with similar outcome
This PHASE3 trial investigates Chronic Heart Failure and Vitamin D Adverse Reaction and is currently terminated or withdrawn. Semmelweis University leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
May 2021 — Jul 2024 [monthly]
Terminated PHASE3
Status: Suspended → Terminated
-
Jan 2021 — May 2021 [monthly]
Suspended PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Suspended PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Suspended PHASE3
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Semmelweis University
For direct contact, visit the study record on ClinicalTrials.gov .